Generation Bio (GBIO) on Monday appointed Kevin Conway as chief financial officer and Phillip Samayoa as chief scientific officer.
The company announced the departure of current CFO Matthew Norkunas, effective Friday, and Chief Scientific Officer Matthew Stanton.
Prior to his appointment, Conway was vice president for finance at Generation Bio, while Samayoa served as the company's chief strategy officer.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.